TD Cowen raised the firm’s price target on McKesson to $499 from $495 and keeps an Outperform rating on the shares. The firm believes distributors can continue to see strength in pharma distribution, driven by strong healthcare utilization as secular tailwinds will continue to drive rising estimates and lead to multiple expansion for the group.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on MCK: